These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7796065)

  • 41. Acute effects of single and repeated electroconvulsive therapy on plasma catecholamines and blood pressure in major depressive disorder.
    Mann JJ; Manevitz AZ; Chen JS; Johnson KS; Adelsheimer EF; Azima-Heller R; Massina A; Wilner PJ
    Psychiatry Res; 1990 Nov; 34(2):127-37. PubMed ID: 2287647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient increase of plasma concentrations of amyloid β peptides after electroconvulsive therapy.
    Zimmermann R; Schmitt H; Rotter A; Sperling W; Kornhuber J; Lewczuk P
    Brain Stimul; 2012 Jan; 5(1):25-9. PubMed ID: 22037136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of electroconvulsive therapy on endorphins in depression.
    Ghadirian AM; Gianoulakis C; Nair NP
    Biol Psychiatry; 1988 Mar; 23(5):459-64. PubMed ID: 2964256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 45. 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT.
    Wilkinson AM; Anderson DN; Abou-Saleh MT; Wesson M; Blair JA; Farrar G; Leeming RJ
    J Affect Disord; 1994 Nov; 32(3):163-8. PubMed ID: 7852658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma noradrenaline response to electroconvulsive therapy in depressive illness.
    Kelly CB; Cooper SJ
    Br J Psychiatry; 1997 Aug; 171():182-6. PubMed ID: 9337957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Biochemical effects of electroconvulsotherapy].
    Benkelfat C
    Encephale; 1988; 14(4):273-81. PubMed ID: 2848680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurophysiological mechanisms of electroconvulsive therapy for depression.
    Kato N
    Neurosci Res; 2009 May; 64(1):3-11. PubMed ID: 19321135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy.
    Sareen J; Enns MW; Guertin JE
    J ECT; 2000 Mar; 16(1):43-51. PubMed ID: 10735331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of electroconvulsive therapy on plasma insulin and glucose in depression.
    Williams K; Smith J; Glue P; Nutt D
    Br J Psychiatry; 1992 Jul; 161():94-8. PubMed ID: 1638337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of lamotrigine on plasma GABA levels in healthy humans.
    Shiah IS; Yatham LN; Gau YC; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):419-23. PubMed ID: 12691776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study.
    Takano H; Motohashi N; Uema T; Ogawa K; Ohnishi T; Nishikawa M; Kashima H; Matsuda H
    Br J Psychiatry; 2007 Jan; 190():63-8. PubMed ID: 17197658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GABA and mood disorders: a brief review and hypothesis.
    Petty F
    J Affect Disord; 1995 Aug; 34(4):275-81. PubMed ID: 8550953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low plasma gamma-aminobutyric acid levels in male patients with depression.
    Petty F; Kramer GL; Gullion CM; Rush AJ
    Biol Psychiatry; 1992 Aug; 32(4):354-63. PubMed ID: 1420649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desipramine does not alter plasma GABA in patients with major depression.
    Petty F; Steinberg J; Kramer GL; Fulton M; Moeller FG
    J Affect Disord; 1993 Sep; 29(1):53-6. PubMed ID: 8254144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ECT for major depression in a patient with acute brain trauma.
    Ruedrich SL; Chu CC; Moore SL
    Am J Psychiatry; 1983 Jul; 140(7):928-9. PubMed ID: 6859320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot study.
    Uchida T; Sugiura Y; Sugiyama E; Maeda R; Tanaka KF; Suematsu M; Mimura M; Uchida H
    Sci Rep; 2023 Aug; 13(1):13218. PubMed ID: 37580528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electroconvulsive therapy and plasma prostaglandin E2 metabolite in major depressive disorder.
    Mathe AA; Bergman P; Aperia B; Wetterberg L
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):701-7. PubMed ID: 2830639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.
    Hestad KA; Tønseth S; Støen CD; Ueland T; Aukrust P
    J ECT; 2003 Dec; 19(4):183-8. PubMed ID: 14657769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression.
    Avissar S; Nechamkin Y; Roitman G; Schreiber G
    Am J Psychiatry; 1998 May; 155(5):666-71. PubMed ID: 9585719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.